David M. Kaye
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

David M. Kaye

Cardiology
27 Rainforest Walk, 
Clayton, VIC, AU 
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
27 Rainforest Walk, 
Clayton, VIC, AU 
OverviewLocationsClinical Research

Overview

David Kaye is a Cardiologist in Clayton, Australia. Mr. Kaye is rated as a Distinguished expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, Heart Transplant, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 420 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 77 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Specialties
Cardiology
Gender
Male

Locations

27 Rainforest Walk, Clayton, VIC 3168, Australia
Other Locations
Wellington Rd, Clayton, VIC 3800, Australia
75 Commercial Rd, Melbourne, VIC 3000, Australia
Wellington Road, Clayton, VIC 3800, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Device
Study Phase: Not Applicable
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Enrollment Status: Unknown
Publish Date: March 07, 2023
Intervention Type: Device
Study Phase: Not Applicable
Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure
Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure
Enrollment Status: Completed
Publish Date: January 11, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

420 Total Publications

Methylene blue in cardiogenic shock and cardiac arrest: A systematic review.
Methylene blue in cardiogenic shock and cardiac arrest: A systematic review.
Journal: Shock (Augusta, Ga.)
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kaye's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile